Overview of Rationale and Criteria for Combining Neoplasms for Evaluation of Preclinical Rodent Carcinogenicity Studies

Overview of Rationale and Criteria for Combining Neoplasms for Evaluation of Preclinical Rodent Carcinogenicity Studies

QIAN Zhuang, ZHANG Yaqun, LI Yanchuan, CHEN Xiaojun, LYU Jianjun

PDF(2203 KB)

主办：上海医药工业研究院
　　　中国药学会
　　　中国化学制药工业协会
ISSN 1001-8255 CN 31-1243/R ZYGZEA

PDF(2203 KB)

Chinese Journal of Pharmaceuticals ›› 2022, Vol. 53 ›› Issue (12) : 1803-1809. DOI: 10.16522/j.cnki.cjph.2022.12.018

Pharmaceutical Management & Information

Overview of Rationale and Criteria for Combining Neoplasms for Evaluation of Preclinical Rodent Carcinogenicity Studies

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 53(12): 1803-1809 https://doi.org/10.16522/j.cnki.cjph.2022.12.018

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(2203 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉